I'm going to ask you one more question—and I see this as an opportunity or a benefit that does come from CETA. Is it correct that with multiple patents that are now on a specific drug, you cannot be taken to court multiple times? Can it be done only once? Can you tell us a bit about that?
On November 29th, 2016. See this statement in context.